|
OSTC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.168300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.068000E-01 |
| Normal-vs-Stage2 |
1.390970E-01 |
| Normal-vs-Stage3 |
3.503400E-03 |
| Normal-vs-Stage4 |
5.039700E-02 |
| Stage1-vs-Stage2 |
2.063000E-01 |
| Stage1-vs-Stage3 |
9.804000E-03 |
| Stage1-vs-Stage4 |
8.145600E-02 |
| Stage2-vs-Stage3 |
2.905000E-01 |
| Stage2-vs-Stage4 |
1.980160E-01 |
| Stage3-vs-Stage4 |
5.528000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.598020E-02 |
| Normal-vs-AfricanAmerican |
1.480810E-01 |
| Normal-vs-Asian |
2.387200E-01 |
| Caucasian-vs-AfricanAmerican |
5.880800E-01 |
| Caucasian-vs-Asian |
8.951600E-01 |
| AfricanAmerican-vs-Asian |
7.439800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.291650E-01 |
| Normal-vs-Female |
4.223700E-04 |
| Male-vs-Female |
1.295660E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.163600E-02 |
| Normal-vs-Extreme_Weight |
1.290630E-01 |
| Normal-vs-Obese |
3.895700E-02 |
| Normal-vs-Extreme_Obese |
9.225800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.599000E-01 |
| Normal_Weight-vs-Obese |
9.398400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.820400E-01 |
| Extreme_Weight-vs-Obese |
4.647200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.693800E-01 |
| Obese-vs-Extreme_Obese |
2.884800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.657690E-02 |
| Normal-vs-Age(41-60Yrs) |
9.318200E-03 |
| Normal-vs-Age(61-80Yrs) |
2.640200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.032200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.538300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.704300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.224400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.693600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.282600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.639200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.498820E-01 |
| Normal-VS-Type2 PRCC |
2.355600E-01 |
| Normal-VS-KIRP CIMP |
7.778000E-03 |
| Normal-VS-Unclassified PRCC |
5.862800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.238600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.842130E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.689700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.643300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.112760E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.888300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.590500E-02 |
| Normal-vs-N1 |
2.822600E-03 |
| Normal-vs-N2 |
7.665900E-02 |
| N0-vs-N1 |
9.202100E-02 |
| N0-vs-N2 |
9.983800E-03 |
| N1-vs-N2 |
1.156650E-01 |
|
|
